About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Rarres1tm1.2Mhl
targeted mutation 1.2, Mi-Hye Lee
MGI:7311668
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Rarres1tm1.2Mhl/Rarres1tm1.2Mhl involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss MGI:7311738
ht2
Rarres1tm1.2Mhl/Rarres1+ involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss MGI:7311756


Genotype
MGI:7311738
hm1
Allelic
Composition
Rarres1tm1.2Mhl/Rarres1tm1.2Mhl
Genetic
Background
involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rarres1tm1.2Mhl mutation (0 available); any Rarres1 mutation (13 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• 77.8% life-time incidence of follicular lymphoma
• lymphoma onset is first detected around 1 year of age
• in some mice, follicular lymphoma shows widespread organ involvement including the liver, mesenteric lymph nodes, inguinal lymph nodes, spleen, pancreas, and cervical lymph nodes
• high grade aggressive follicular lymphoma has characteristics of diffuse large B-cell lymphoma
• however, mice do not show increased incidence of epithelial cancers

immune system
• B cells are maintained in a less differentiated state
• splenic B cells activated in vitro by stimulation with anti-IgM, anti-CD40, and IL-4 (modeling T cell-dependent activation in B cells) show reduced plasma cell differentiation
• splenic B cells activated in vitro by stimulation with anti-IgM, anti-CD40, and IL-4 (modeling T cell-dependent activation in B cells) show reduced germinal center B cell formation
• B cells accumulate at the G0/G1 phase of the cell cycle after 3 days of T cell-dependent activation thus there is an increased number of B cells in G0/G1 and fewer in S and G2/M
• B cells show a small but significant decrease in the levels of NAD+
• however, B cells do not alter mitochondrial oxidative phosphorylation after 24 hours of T cell-dependent activation
• resting B cells undergo slightly decreased levels of apoptosis, but the magnitude of protection from apoptosis is not commensurate with the increase in cell viability
• splenic B cells activated in vitro by stimulation with anti-IgM, anti-CD40, and IL-4 (modeling T cell-dependent activation in B cells) show decreased IgG1 production, reduced germinal center B cell formation, and reduced plasma cell differentiation
• resting (unstimulated) B cells are more viable after 3 days in culture while 3-day T cell-dependent activated B cells show only a marginal increase in viability

hematopoietic system
• B cells are maintained in a less differentiated state
• splenic B cells activated in vitro by stimulation with anti-IgM, anti-CD40, and IL-4 (modeling T cell-dependent activation in B cells) show reduced plasma cell differentiation
• mice show survival of CD45+ cells within the liver up to 3 months postnatally suggesting extramedullary hematopoiesis even after birth
• however, mature blood cell and hematopoietic stem progenitor cell (HSPC) numbers are normal, with no changes in T cells and B cells, numbers of macrophages, granulocytes, NK cells, and plasma cells, and normal levels of multipotent progenitor cells and
• splenic B cells activated in vitro by stimulation with anti-IgM, anti-CD40, and IL-4 (modeling T cell-dependent activation in B cells) show reduced germinal center B cell formation
• B cells accumulate at the G0/G1 phase of the cell cycle after 3 days of T cell-dependent activation thus there is an increased number of B cells in G0/G1 and fewer in S and G2/M
• B cells show a small but significant decrease in the levels of NAD+
• however, B cells do not alter mitochondrial oxidative phosphorylation after 24 hours of T cell-dependent activation
• resting B cells undergo slightly decreased levels of apoptosis, but the magnitude of protection from apoptosis is not commensurate with the increase in cell viability
• splenic B cells activated in vitro by stimulation with anti-IgM, anti-CD40, and IL-4 (modeling T cell-dependent activation in B cells) show decreased IgG1 production, reduced germinal center B cell formation, and reduced plasma cell differentiation
• resting (unstimulated) B cells are more viable after 3 days in culture while 3-day T cell-dependent activated B cells show only a marginal increase in viability

cellular
• mouse embryonic fibroblasts (MEFs) exhibit increased levels of basal/maximum oxygen consumption, ATP production, and spare respiratory capacity
• resting B cells undergo slightly decreased levels of apoptosis, but the magnitude of protection from apoptosis is not commensurate with the increase in cell viability
• resting (unstimulated) B cells are more viable after 3 days in culture while 3-day T cell-dependent activated B cells show only a marginal increase in viability

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
follicular lymphoma DOID:0050873 OMIM:151430
J:324270




Genotype
MGI:7311756
ht2
Allelic
Composition
Rarres1tm1.2Mhl/Rarres1+
Genetic
Background
involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rarres1tm1.2Mhl mutation (0 available); any Rarres1 mutation (13 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• 44.4% life-time incidence of follicular lymphoma
• follicular lymphoma organ involvement is less widespread than in homozygotes and is focused in the liver, mesenteric lymph nodes, and inguinal lymph nodes

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
follicular lymphoma DOID:0050873 OMIM:151430
J:324270





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory